224 related articles for article (PubMed ID: 21097744)
41. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
[TBL] [Abstract][Full Text] [Related]
42. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis.
Corner LA; Costello E; O'Meara D; Lesellier S; Aldwell FE; Singh M; Hewinson RG; Chambers MA; Gormley E
Vaccine; 2010 Aug; 28(38):6265-72. PubMed ID: 20637774
[TBL] [Abstract][Full Text] [Related]
43. Idiopathic disseminated bacillus Calmette-Guerin infection in three infants.
Kido J; Mizukami T; Ohara O; Takada H; Yanai M
Pediatr Int; 2015 Aug; 57(4):750-3. PubMed ID: 26044661
[TBL] [Abstract][Full Text] [Related]
44. Retroperitoneal abscess due to disseminated Bacille Calmette-Guérin infection.
Alborzi A; Mostafavi N
Jpn J Infect Dis; 2007 Nov; 60(6):392-3. PubMed ID: 18032842
[TBL] [Abstract][Full Text] [Related]
45. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.
Rabie H; Violari A; Duong T; Madhi SA; Josipovic D; Innes S; Dobbels E; Lazarus E; Panchia R; Babiker AG; Gibb DM; Cotton MF;
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1194-200, i. PubMed ID: 21943845
[TBL] [Abstract][Full Text] [Related]
46. Complications of bacillus Calmette-Guérin immunization in children treated with highly-active antiretroviral therapy.
Fernandes RC; Medina-Acosta E
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e361. PubMed ID: 20207181
[No Abstract] [Full Text] [Related]
47. Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study.
Casanova JL; Blanche S; Emile JF; Jouanguy E; Lamhamedi S; Altare F; Stéphan JL; Bernaudin F; Bordigoni P; Turck D; Lachaux A; Albertini M; Bourrillon A; Dommergues JP; Pocidalo MA; Le Deist F; Gaillard JL; Griscelli C; Fischer A
Pediatrics; 1996 Oct; 98(4 Pt 1):774-8. PubMed ID: 8885960
[TBL] [Abstract][Full Text] [Related]
48. Tuberculosis and HIV co-infections in Jamaican children.
Geoghagen M; Farr JA; Hambleton I; Pierre R; Christie CD
West Indian Med J; 2004 Oct; 53(5):339-45. PubMed ID: 15675501
[TBL] [Abstract][Full Text] [Related]
49. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
Sohail S; Afzal M; Anwar V; Shama Q
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795
[TBL] [Abstract][Full Text] [Related]
50. BCG-osis and tuberculosis in a child with chronic granulomatous disease.
Bustamante J; Aksu G; Vogt G; de Beaucoudrey L; Genel F; Chapgier A; Filipe-Santos O; Feinberg J; Emile JF; Kutukculer N; Casanova JL
J Allergy Clin Immunol; 2007 Jul; 120(1):32-8. PubMed ID: 17544093
[TBL] [Abstract][Full Text] [Related]
51. Detection of bloodstream pathogens in a bacille Calmette-Guérin (BCG)-vaccinated pediatric population in Malawi: a pilot study.
Archibald LK; Nwanyanwu O; Kazembe PN; Mwansambo C; Bell M; Dobbie H; Reller LB; Jarvis WR
Clin Microbiol Infect; 2003 Mar; 9(3):234-8. PubMed ID: 12667257
[TBL] [Abstract][Full Text] [Related]
52. Novel vaccine prime and selective BCG boost: a new tuberculosis vaccine strategy for infants of HIV-infected mothers.
Hatherill M; Mahomed H; Hanekom W
Vaccine; 2010 Jun; 28(29):4550-2. PubMed ID: 20470797
[TBL] [Abstract][Full Text] [Related]
53. Pathologic findings for bacille Calmette-Guérin infections in immunocompetent and immunocompromised patients.
al-Bhlal LA
Am J Clin Pathol; 2000 May; 113(5):703-8. PubMed ID: 10800403
[TBL] [Abstract][Full Text] [Related]
54. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
[TBL] [Abstract][Full Text] [Related]
55. Pediatric tuberculosis: global overview and challenges.
Swaminathan S; Rekha B
Clin Infect Dis; 2010 May; 50 Suppl 3():S184-94. PubMed ID: 20397947
[TBL] [Abstract][Full Text] [Related]
56. Regional Bacillus Calmette-Guérin lymphadenitis after initiating antiretroviral therapy in an infant with human immunodeficiency virus type 1 infection.
Sharp MJ; Mallon DF
Pediatr Infect Dis J; 1998 Jul; 17(7):660-2. PubMed ID: 9686741
[No Abstract] [Full Text] [Related]
57. Disseminated bacille Calmette-Guérin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome.
Bukhari E; Alaklobi F; Bakheet H; Alrabiaah A; Alotibi F; Aljobair F; Alshamrani M; Alaki E; Alnahdi F; Alodyani A; Alzamil F
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3696-702. PubMed ID: 27649674
[TBL] [Abstract][Full Text] [Related]
58. Assessment of bacille Calmette-Guérin vaccine reaction in HIV-exposed Thai infants.
Chokephaibulkit K; Chotpitayasunondh T; Vanprapar N; Waranawat N; Mock PA; McConnell MS; Jetswang B; Neeyapun K; Tappero JW; Culnane M
Clin Infect Dis; 2007 Oct; 45(8):1016-8. PubMed ID: 17879918
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous complication after BCG vaccination: case report and review of the literature.
Keijsers RR; Bovenschen HJ; Seyger MM
J Dermatolog Treat; 2011 Dec; 22(6):315-8. PubMed ID: 20964574
[TBL] [Abstract][Full Text] [Related]
60. Bacille Calmette-Guerin (BCG) complications in children with severe combined immunodeficiency (SCID).
Barkai G; Somech R; Stauber T; Barziali A; Greenberger S
Infect Dis (Lond); 2019 Aug; 51(8):585-592. PubMed ID: 31204539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
